Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about UCBJF

Recent news which mentions UCBJF

Protagonist/Johnson & Johnson Partnered Drug Shows Significant Skin Clearance In Pivotal Psoriasis Study
Tickers JNJ NEWS NVS PTGX
Tags Benzinga Stories That Matter Health Care
From Benzinga
Pharma Industry Faces Jitters As Trump Hints At Historic Tariffs, BofA Outlines Probable Timeline
Tickers ARGX AZN GILD GSK
Tags Analyst Color GILD Top Stories
From Benzinga
Pharmaceutical Firms Say UK Investment Is 'Unlikely' Unless Payment Levy Is Adressed
Tickers AMGN AZN BIIB BMY
Tags General Market News GILD
From Benzinga
Europe-Based UCB's Bimzelx Data Reveals Sustained Skin Clearance In Inflammatory Skin Disorders
Tickers NEWS UCBJF UCBJY
Tags Biotech Eurozone Benzinga
From Benzinga
Biogen Gains Momentum With Positive Lupus Drug Results, Analyst Sees Modest Valuation Upside
Tickers BIIB NEWS UCBJF UCBJY
Tags Analyst Color Expert Ideas UCBJF
From Benzinga
FDA Approves UCB's Psoriasis Drug For Expanded Use In Painful Inflammatory Skin Disease
Tickers NEWS UCBJF UCBJY
Tags Biotech Health Care UCBJY
From Benzinga
Biogen/UCB Partnered Autoimmune Disease Candidate Hits Primary Goal In Late-Stage Study, Sets Stage Another Pivotal Trial
Tickers BIIB NEWS UCBJF UCBJY
Tags Biotech Benzinga Stories That Matter
From Benzinga
Longboard Pharmaceuticals Boasts High-Value Epilepsy Assets, Analyst Initiates Coverage
Tickers LBPH NEWS UCBJF UCBJY
Tags Analyst Ratings Biotech Benzinga
From Benzinga
Johnson & Johnson Seeks FDA Approval For Muscle Weakness Drug And Gears Up Showdown With Argenx and UCB
Tickers ARGX JNJ NEWS UCBJF
Tags Health Care UCBJY FDA
From Benzinga
Belgium-Based Pharma Firm UCB To Offload China Neurology, Allergy Business For $680M To Asset Management Companies
Tickers NEWS UCBJF UCBJY
Tags General Briefs Market News
From Benzinga
There's Optimism Around Longboard Pharmaceuticals' Anti-Seizure Candidate: Analyst Boosts Price Target
Tickers LBPH NEWS UCBJF UCBJY
Tags Analyst Ratings Biotech Benzinga
From Benzinga
Dianthus' Monoclonal Antibody On Promising Pathway To Gaining The Upper Hand - Analyst
Tickers AZN DNTH SNY UCBJF
Tags Equities Biotech Analyst Ratings
From Benzinga
Skin Disease Focused MoonLake Immunotherapeutics Poised To Outshine Rivals, Analyst Asserts
Tickers MLTX SLRN UCBJF UCBJY
Tags General Briefs Market News
From Benzinga
FDA Approves Rystiggo: The Only Treatment for Two Most Common Subtypes of Generalized Myasthenia Gravis in Adults
Tickers ARGX UCBJF UCBJY
Tags Benzinga FDA UCBJY
From Benzinga
Cantor On MoonLake Immunotherapeutics - Initiates On Inexpensive Valuation, Strong Catalyst Path
Tickers MLTX NVS UCBJF UCBJY
Tags Benzinga Trading Ideas Health Care
From Benzinga
UCB's Rare Childhood Epilepsy Drug Scores FDA Approval
Tickers UCBJF UCBJY
Tags Biotech News UCBJF
From Benzinga
Biogen-Xbrane Enter License Agreement For Cimzia Referenced Biosimilar, Xcimzane
Tickers BIIB UCBJF UCBJY
Tags Contracts Benzinga UCBJY
From Benzinga
UCB's Bispecific Marks Phase 3 Win For Second Psoriatic Arthritis Study
Tickers UCBJF UCBJY
Tags Biotech Phase 3 Trial News
From Benzinga
Why Zogenix Flew Higher Before Leveling Off This Week
Tickers UCBJF ZGNX
Tags Market News Recent Press Releases UCBJF
From Motley Fool
UCB to Buy Epilepsy-Focused Zogenix In $1.9B Deal: See The Highlights
Tickers UCBJF ZGNX
Tags Briefs General Market News
From Benzinga
UCB Gets EU Approval For Bimekizumab In Psoriasis
Tickers NVS UCBJF UCBJY
Tags Trading Ideas Benzinga FDA
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.